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The oral administration route is the one most preferred by patients. The digestive system 
presents several challenges: the low gastric pH, the intestinal mucus and the presence of 
enzymes can all reduce the therapeutic effect of the active pharmaceutical ingredient 
(API). Capsules and tablets are commonly used dosage forms in clinical practice. 
Nevertheless, in these drug delivery systems (DDS), the API is released in an 
omnidirectional manner entailing an unavoidable loss of the therapeutic substance in the 
intestinal lumen. Microcontainers (Fig. 1 a) are micro-fabricated cylindrical reservoirs filled 
with the API which can be used as a multi-particulate system with an intrinsic 
unidirectional release due to their geometry1. Hereby, we present the in vivo and ex vivo 
performances of microcontainers as DDS for ketoprofen chosen as poorly soluble model 
drug. Microcontainers were filled with polyvinyl pyrrolidone (PVP, 104 Da) and loaded with 
ketoprofen by supercritical CO2 assisted-impregnation2. The cavities of the 
microcontainers were sealed with an enteric coating (Eudragit L100/dibutyl sebacate) 
deposited via spray coating to activate the drug release upon reaching the intestinal pH3. 
The DDS was characterized both in vitro, in vivo (Fig.1 b) and ex vivo (Fig. 1 c). The 
results suggest the suitability of the microcontainers as carriers for other APIs, such as 
insulin or the already in vitro tested Cyclosporin A. 
 
 
Figure 1 – a) SEM image of a loaded and coated microcontainer; b) Plasma 
concentration-time profile of ketoprofen in orally dosed with the aforementioned DDS rats; 
c) Optical micrograph of microcontainers within rat´s jejunum after oral administration (ex 
vivo study). 
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